Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
2003 1
2004 1
2008 1
2014 2
2015 1
2017 1
2018 1
2019 4
2020 1
2021 1
2022 5
2023 3
2024 1
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Once-Weekly Semaglutide in Adolescents with Obesity.
Weghuber D, Barrett T, Barrientos-Pérez M, Gies I, Hesse D, Jeppesen OK, Kelly AS, Mastrandrea LD, Sørrig R, Arslanian S; STEP TEENS Investigators. Weghuber D, et al. N Engl J Med. 2022 Dec 15;387(24):2245-2257. doi: 10.1056/NEJMoa2208601. Epub 2022 Nov 2. N Engl J Med. 2022. PMID: 36322838 Free PMC article. Clinical Trial.
Liraglutide in Children and Adolescents with Type 2 Diabetes.
Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T; Ellipse Trial Investigators. Tamborlane WV, et al. N Engl J Med. 2019 Aug 15;381(7):637-646. doi: 10.1056/NEJMoa1903822. Epub 2019 Apr 28. N Engl J Med. 2019. PMID: 31034184 Clinical Trial.
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA.
Nasonov EL, Mazurov VI, Lila AM, Dubinina TV, Gaidukova IZ, Lapshina SA, Klimenko AA, Somov DV, Lukyanov SA, Chudakov DM, Zvyagin IV, Britanova OV, Korolev MA, Abdulganieva DI, Krechikova DG, Kastanayan AA, Eliseeva LV, Samigullina RR, Povarova TV, Antipova OV, Smakotina SA, Soboleva VN, Nesmeyanova OB, Plaksina TV, Soroka NF, Vinogradova IB, Rebrov AP, Kropotina TV, Maslyansky AL, Zinkina-Orikhan AV, Linkova YN, Pukhtinskaya PS, Morozova MA, Vinderskaya GA. Nasonov EL, et al. Among authors: dubinina tv. Dokl Biochem Biophys. 2025 Jun;522(1):387-403. doi: 10.1134/S1607672925700140. Epub 2025 May 11. Dokl Biochem Biophys. 2025. PMID: 40353961 Clinical Trial.
Comparative Characteristics of Axial Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
Gubar EE, Korotaeva TV, Dubinina TV, Vorobyova LD, Tremaskina PO, Agafonova EM, Korsakova YL, Loginova EY, Sakharova KV, Sablina AO, Smirnov AV, Erdes SF, Urumova MM, Glukhova SI. Gubar EE, et al. Among authors: dubinina tv. Dokl Biochem Biophys. 2025 Jun;522(1):343-351. doi: 10.1134/S1607672925700103. Epub 2025 May 11. Dokl Biochem Biophys. 2025. PMID: 40353967
[Spondyloarthritis: modern terminology and definitions].
Erdes SF, Rebrov AP, Dubinina TV, Badokin VV, Bochkova AG, Bugrova OV, Gaydukova IZ, Godzenko AA, Dubikov AA, Ivanova ON, Korotaeva TV, Lapshina SA, Nesmeyanova OB, Nikishina IP, Otteva EN, Raskina TA, Rumyantseva OA, Sitalo AV, Smirnov AV. Erdes SF, et al. Among authors: dubinina tv. Ter Arkh. 2019 May 15;91(5):84-88. doi: 10.26442/00403660.2019.05.000208. Ter Arkh. 2019. PMID: 32598681 Russian.
Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study.
Mazurov VI, Dubinina TV, Erdes S, Lapshina SA, Soroka NF, Kunder EV, Smirnov AV, Eremeeva AV, Zinkina-Orikhan AV, Morozova MA, Gaydukova IZ. Mazurov VI, et al. Among authors: dubinina tv. Clin Exp Rheumatol. 2023 Mar;41(3):718-726. doi: 10.55563/clinexprheumatol/ljpqqe. Epub 2022 Aug 31. Clin Exp Rheumatol. 2023. PMID: 36062743 Clinical Trial.
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y).
Landewé RB, Gensler LS, Poddubnyy D, Rahman P, Hojnik M, Li X, Liu Leage S, Adams D, Carlier H, Van den Bosch F; COAST-Y study group. Landewé RB, et al. Ann Rheum Dis. 2021 Aug;80(8):1022-1030. doi: 10.1136/annrheumdis-2020-219717. Epub 2021 May 6. Ann Rheum Dis. 2021. PMID: 33958326 Free PMC article. Clinical Trial.
25 results